Otti Bengtsson Gref
Geen lopende functies
Profiel
Otti Bengtsson Gref worked as Director of Research & Development at Cavidi AB and Vice President of Research & Development at Biovica International AB.
She obtained an undergraduate degree from the University of Uppsala and a Master's in Business Administration from Mgruppen Svenska Managementgruppen AB.
Eerdere bekende functies van Otti Bengtsson Gref
Bedrijven | Functie | Einde |
---|---|---|
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Chief Tech/Sci/R&D Officer | - |
BIOVICA INTERNATIONAL AB | Chief Tech/Sci/R&D Officer | - |
Opleiding van Otti Bengtsson Gref
University of Uppsala | Undergraduate Degree |
Mgruppen Svenska Managementgruppen AB | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOVICA INTERNATIONAL AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Health Technology |